ArticleJournal of thoracic disease2025
Utilizing spectral detector computed tomography quantitative parameters via multimodality tumor tracking to predict occult lymph node metastasis in clinical stage 1 pure solid lung adenocarcinoma.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- FDG-PET/CT data enhances machine learning prediction of occult lymph-node metastasis in lung adenocarcinoma.Journal of thoracic disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The presence of occult lymph node metastasis (OLNM) has significant implications for the staging, treatment and prognosis of patients with tumors. This study aimed to explore the potential predictive value of dual-layer spectral detector computed tomography (SDCT) quantitative parameters obtained via multimodal tumor tracking (MMTT) for OLNM in clinical stage 1 (c1) pure solid lung adenocarcinoma (LAC). Methods: A total of 123 patients diagnosed with c1 pure solid LAC were enrolled in this retrospective study, including 29 OLNM(+) and 94 OLNM(-) patients. MMTT was used to obtain the full volume of the tumor and extract quantitative spectral parameters. The differences in clinicopathological data and spectral quantitative parameters between OLNM(+) and OLNM(-) were compared, and the efficacy of related quantitative parameters in predicting OLNM were evaluated through receiver operating characteristic (ROC) curves. Five different machine learning (ML) methods were applied to construct a forecasting OLNM model. Results: The tumor volume (3.868 Conclusions: SDCT quantitative parameters obtained via MMTT might offer new insights to help predict OLNM in c1 pure solid LAC patients. The prediction model constructed with the MLP model on the basis of clinicopathological data and spectral quantitative parameters has higher diagnostic efficiency and may further aid in clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.